Daniel Yeung

Daniel Yeung

Auto-generated profile, based on publicly available information

Daniel Yeung

University of Florida Proton Therapy Institute

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1996 in Medical Physics
Verified
Journal Article
Closed access
JPJatinder R. Palta
Jatinder R. Palta
DYDaniel K. Yeung
Daniel K. Yeung
VFVincent Frouhar
Vincent Frouhar

2 September 2013 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
DYDaniel Yeung
Daniel Yeung
CMCraig McKenzie
Craig McKenzie
DIDaniel J. Indelicato
Daniel J. Indelicato

1 January 2013
Verified
Book Chapter
Closed access
PDF file
DYDaniel Yeung
Daniel Yeung
JPJatinder Palta
Jatinder Palta

28 October 2009 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
RMRobert S. Malyapa
Robert S. Malyapa
WMWilliam M. Mendenhall
William M. Mendenhall
ZLZuofeng Li
Zuofeng Li
DYDaniel Yeung
Daniel Yeung
NMNancy P. Mendenhall
Nancy P. Mendenhall
Introduction: Twenty-one patients with tumors in the paranasal sinus region with skull base extension have received high-dose proton therapy at UFPTI since January of 2007. The disease characteristics, treatment planning and delivery techniques, and initial follow-up results are presented. Methods: Of the 21 patients, 18 had prior surgery, 10 with positive margins. Three patients had biopsy only. Histology included poorly differentiated carcinomas, sinonasal undifferentiated carcinoma, adenocarcinoma, mucosal melanoma, and adenoid cystic carcinoma. Proton treatment targets and critical structures were delineated from co-registered simulation CT images and diagnostic MR images. The geometric relations between target volumes and critical structures were examined to select optimal proton beam parameters. Proton-specific through fields, patch fields, and match fields were used for these patients to achieve target-conforming and critical organ-sparing concave dose distributions. Prescribed dose ranges from 69.6 CGE to 74.4 CGE were delivered at 1.2 CGE per fraction, two fractions per day. Proton treatments were delivered with orthogonal kV x-ray imaging guidance, to achieve 1-mm patient setup accuracy for each fraction. Results: Patient follow-ups ranged from 1 to 21 months, with mean of 10.4 months. All patients tolerated treatments well. Patients had brisk skin reactions that resolved within 4 weeks after completion of treatments. Follow-up CT and MR scans revealed in-field recurrent disease in one patient at 9 months, and progressive meningeal seeding in one patient within 2 months after completion of treatment. Medial retinopathy occurred within the treated volume in one patient at 11 months after completion of treatment without negative impact in visual acuity. Conclusion: Our experience suggests that patients with tumors involving the skull base will benefit from high-dose conformal proton therapy treatments.

1 January 2013
Verified
Book Chapter
Closed access
PDF file
DYDaniel Yeung
Daniel Yeung
JPJatinder Palta
Jatinder Palta

1 January 2013
Verified
Book Chapter
Closed access
PDF file
DYDaniel Yeung
Daniel Yeung
JPJatinder Palta
Jatinder Palta